Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis
Urology Research and Practice · 01.11.2021 · 47 (6) · 482-488
DOI: 10.5152/tud.2021.21206 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Urology Research and Practice, online erschienen am 01.11.2021. Verfasst von Dwi Nanda Satriyo Arif Wibowo und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Universitas Airlangga Faculty of Medicine, Dr. Soetomo General- Academic Hospital, Surabaya, Indonesia. Die Arbeit wurde bisher 25-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
In recent years, several studies have reported promising results of Yohimbine as a natural supplement for erectile dysfunction (ED). However, several studies suggested that the aphrodisiac effects of the extract were only a placebo or due to the increase in peripheral vascular congestion. In contrast, other studies reported that it could provide excellent curative effects on organic impotence. We aimed to review the efficacy of Yohimbine as a pharmacological treatment for ED and performed a comprehensive systematic search of published articles in PubMed and Science Direct databases for eligible randomized controlled trials comparing Yohimbine to placebo or no treatment for ED patients. A total of eight studies out of 543 studies were included in this review. Both Yohimbine alone (odds ratio [OR] ¼ 2.08, 95% CI 1.30-3.32, P ¼ .002) and combined (OR ¼ 6.35, 95% CI 3.01-13.41, P < .001) showed a significantly greater probability of erectile function improvement compared to the placebo group (OR ¼ 2.87, 95% CI 1.94-4.25, P < .001). Yohimbine alone did not show a significant difference in the rate of improved sexual function (P ¼ .07); however, the pooled results of both subgroups indicated a higher rate of improved sexual function (OR ¼ 2.65, 95% CI 1.43-4.92, P ¼ .002). Sole administration of Yohimbine and its combination with other supplements can improve the erectile function in ED patients. However, it is not able to improve the sexual function if not combined with other treatments. Cite this article as: Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Turk J Urol. 2021;47(6):482-488
Autor:innen und Institutionen
- Department of Urology, Universitas Airlangga Faculty of Medicine, Dr. Soetomo General- Academic Hospital, Surabaya, Indonesia.
Zitieren
APA
Wibowo, D. N. S. A., Soebadi, D. M., & Soebadi, M. A. (2021). Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Urology Research and Practice, 47(6), 482-488. https://doi.org/10.5152/tud.2021.21206
Vancouver
Wibowo DNSA, Soebadi DM, Soebadi MA. Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis. Urology Research and Practice. 2021;47(6):482-488. doi:10.5152/tud.2021.21206
BibTeX
@article{Wibowo2021,
author = {Wibowo, Dwi Nanda Satriyo Arif and Soebadi, Doddy Moesbadianto and Soebadi, Mohammad Ayodhia},
title = {Yohimbine as a treatment for erectile dysfunction: A systematic review and meta-analysis},
journal = {Urology Research and Practice},
year = {2021},
volume = {47},
number = {6},
pages = {482--488},
doi = {10.5152/tud.2021.21206}
}
EUVIMED